Skip to content

Exercise Training and Hepatic Metabolism in Overweight/Obese Adolescent

Effects of an Exercise Program on Hepatic Metabolism and Cardiovascular Health in Overweight/Obese Adolescent From Bogota, Colombia (HEPAFIT Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02753231
Acronym
HEPAFIT
Enrollment
120
Registered
2016-04-27
Start date
2017-01-31
Completion date
2017-12-31
Last updated
2018-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition, Beneficial, Lipid Metabolism Disorders, Mental Health Wellness 1, Metabolic Syndrome X, Obesity

Brief summary

The HEPAFIT Study aims to examine whether a 6-months physical education program has benefits on hepatic metabolism and cardiovascular health as well as on selected physical fitness and mental health outcomes among adolescent overweight/obese from Bogota, Colombia.

Interventions

BEHAVIORALLow physical activity program

Exercise will be performed at three sessions per week. All sessions will be supervised by a trained health or exercise professional.

BEHAVIORALHigh physical activity program

Exercise will be performed at three sessions per week. All sessions will be supervised by a trained health or exercise professional.

BEHAVIORALLow and High physical activity program

Exercise will be performed at three sessions per week. All sessions will be supervised by a trained health or exercise professional.

BEHAVIORALConventional physical activity program

One Physical Education sessions / week

Sponsors

Universidad de Santiago de Chile
CollaboratorOTHER
Universidad de Granada
CollaboratorOTHER
Universidad Pública de Navarra
CollaboratorOTHER
Emory University
CollaboratorOTHER
University of Castilla-La Mancha
CollaboratorOTHER
Universidad Santo Tomas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
11 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Overweight or obesity status * 11-17 years old * Written informed consent * Interested in improving health and fitness

Exclusion criteria

* Any other conditions which, in opinion of the investigators, would adversely affect the conduct of the trial. * Clinical diagnosis of diabetes * Pregnancy * Drugs/alcohol abuse

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in hepatic fat measured by controlled attenuation parameter values (FibroScan®)Baseline and 6 monthsChanges in hepatic fat fraction measured by controlled attenuation parameter after the 6 months intervention program

Secondary

MeasureTime frameDescription
Changes in serum lipid profileBaseline and 6 monthsChanges in cholesterol total, LDL cholesterol, HDL cholesterol and triglycerides after the 6 months intervention program
Changes in Insulin sensitivity measured by homeostasis model assessment (HOMA)Baseline and 6 monthsChanges in insulin sensitivity measured by homeostasis model assessment (HOMA) after the 6 months intervention program
Change from Baseline in Aerobic fitness measured on a maximum effort testBaseline and 6 monthsChange from Baseline in Cardiorespiratory fitness measured on a maximum effort test
Change from Baseline in Muscular Fitness assessed using handgrip test (maximum handgrip strength assessment)Baseline and 6 monthsMuscular fitness will be assessed using handgrip test (maximum handgrip strength assessment) using a standard adjustable handle analogue handgrip dynamometer T-18 TKK SMEDLY III®
Changes in liver enzymesBaseline and 6 monthsChanges in total alanine transaminase (ALT) after the 6 months intervention program
Changes in physical activity using accelerometryBaseline and 6 monthsChanges in physical activity estimated by accelerometry after the 6 months intervention program
Change from Baseline in Quality & satisfaction with life by SF Community - short-form survey (SF-12™) Colombian versionBaseline and 6 months
Changes in blood pressureBaseline and 6 monthsChanges in blood pressure after the 6 months intervention program
Changes in inflammatory markers after the 6 months intervention programBaseline and 6 monthsChanges in TNF-alpha after the 6 months intervention program
Change from Baseline in Body compositionBaseline and 6 monthsFat mass as measured by Dual Energy X-ray Absorptiometry

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026